Boston Scientific BOSTON Bond
BSX Stock | EUR 86.50 0.50 0.58% |
Boston Scientific holds a debt-to-equity ratio of 0.593. . Boston Scientific's financial risk is the risk to Boston Scientific stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Boston Scientific's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Boston Scientific's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Boston Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Boston Scientific's stakeholders.
For most companies, including Boston Scientific, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Boston Scientific, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Boston Scientific's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Boston |
Given the importance of Boston Scientific's capital structure, the first step in the capital decision process is for the management of Boston Scientific to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Boston Scientific to issue bonds at a reasonable cost.
Popular Name | Boston Scientific BOSTON SCIENTIFIC PORATION |
Equity ISIN Code | US1011371077 |
Bond Issue ISIN Code | US101137AW79 |
S&P Rating | Others |
Maturity Date | Others |
Issuance Date | Others |
Coupon | 3.75 % |
Boston Scientific Outstanding Bond Obligations
Boeing Co 2196 | US097023DG73 | Details | |
HSBC Holdings PLC | US404280DR76 | Details | |
BOSTON PPTYS LTD | US10112RAZ73 | Details | |
BOSTON PPTYS LTD | US10112RAY09 | Details | |
BOSTON PPTYS LTD | US10112RAX26 | Details | |
BXP 675 01 DEC 27 | US10112RBG83 | Details | |
BOSTON SCIENTIFIC P | US101137AL15 | Details | |
BXP 245 01 OCT 33 | US10112RBF01 | Details | |
BOSTON PROPERTIES LP | US10112RBE36 | Details | |
BOSTON PROPERTIES LP | US10112RBD52 | Details | |
US10112RBC79 | US10112RBC79 | Details | |
BOSTON PROPERTIES LP | US10112RBB96 | Details | |
BOSTON PPTYS LTD | US10112RBA14 | Details | |
US101137AE71 | US101137AE71 | Details | |
BOSTON SCIENTIFIC PORATION | US101137BA41 | Details | |
US101137AZ01 | US101137AZ01 | Details | |
BOSTON SCIENTIFIC PORATION | US101137AX52 | Details | |
BOSTON SCIENTIFIC PORATION | US101137AW79 | Details | |
BOSTON SCIENTIFIC PORATION | US101137AU14 | Details | |
BOSTON SCIENTIFIC PORATION | US101137AT41 | Details | |
BOSTON SCIENTIFIC P | US101137AS67 | Details | |
MGM Resorts International | US552953CD18 | Details | |
AerCap Global Aviation | US00773HAA59 | Details |
Understaning Boston Scientific Use of Financial Leverage
Boston Scientific's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Boston Scientific's total debt position, including all outstanding debt obligations, and compares it with Boston Scientific's equity. Financial leverage can amplify the potential profits to Boston Scientific's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Boston Scientific is unable to cover its debt costs.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENTIFIC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38000 people. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.